Report - BASEL · Adapted from Hedge et al., Clin Cancer Res, 2016 IPH5401 Anti-C5aR Lirilumab Anti-KIR2DL1,2,3 IPH53 Anti-CD73 IPH4301 Anti-MICA/B NK Bispecific Engagers Antibody Drug Conjugates

Please pass captcha verification before submit form